TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18420851

Group type: EXPERIMENTAL
Intervention: Droperidol 1.25 mg (group D)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Haloperidol 2 mg (group H)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Dexamethasone 5 mg (group Dx)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Haloperidol 2 mg plus Dexamethasone 5 mg (group H + Dx)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Saline (group S)
Number of subjects: 400
Study: 16838151

Group type: EXPERIMENTAL
Intervention: POC aPTT
Number of subjects: 126

Group type: COMPARATOR
Intervention: Lab aPTT
Number of subjects: 126
Study: 14500439

Group type: EXPERIMENTAL
Intervention: Nurse led education and direct access service
Number of subjects: 107000
Study: 11023502

Group type: EXPERIMENTAL
Intervention: Donor lymphocyte infusions (DLI) - bulk-dose (n = 34) or escalating-dose (n = 32) regimen
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Donor lymphocyte infusions (DLI)
Number of subjects: 66

Group type: COMPARATOR
Intervention: No intervention (failure to achieve molecular remission)
Number of subjects: 66
Study: 8777103

Group type: EXPERIMENTAL
Intervention: Halothane (1 MAC end-tidal concentration)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Isoflurane (1 MAC end-tidal concentration)
Number of subjects: 40
Study: 1505611

Group type: EXPERIMENTAL
Intervention: Ethanol (high dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ethanol (low dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lorazepam (high dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lorazepam (low dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Triprolidine (high dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Triprolidine (low dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6671847

Group type: EXPERIMENTAL
Intervention: Aversion therapy with covert imagery and electric shock
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 30689727

Group type: EXPERIMENTAL
Intervention: WHEY diet (N = 10; 0.90 ± 0.01 g protein/kg/day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: MIXED diet (N = 10; 0.97 ± 0.01 g protein/kg/day)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both diets
Number of subjects: 20
Study: 28665227

Group type: EXPERIMENTAL
Intervention: Incidental affect (feeling good/bad)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 59
Study: 26137923

Group type: EXPERIMENTAL
Intervention: Motivational interviewing and self-regulation coaching intervention (1 motivational interview and 2 self-regulation coaching sessions)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Patient-education session (control group)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Motivational interviewing and self-regulation coaching intervention
Number of subjects: 78
Study: 24678955

Group type: EXPERIMENTAL
Intervention: Darapladib (160 mg once daily)
Number of subjects: 15828

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15828
Study: 22161025

Group type: EXPERIMENTAL
Intervention: Mindfulness training (MT) for 8 weeks
Number of subjects: 75

Group type: COMPARATOR
Intervention: Social support group
Number of subjects: 75
Study: 20954778

Group type: EXPERIMENTAL
Intervention: Telephone-counseling intervention (TC; n = 228)
Number of subjects: 434

Group type: COMPARATOR
Intervention: Usual care (UC; n = 206)
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Telephone-counseling intervention (TC)
Number of subjects: 434

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 434
Study: 17050593

Group type: EXPERIMENTAL
Intervention: Live attenuated influenza virus vaccine (LAIV)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inactivated influenza virus vaccine (TIV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 15893877

Group type: EXPERIMENTAL
Intervention: Sentences with subject-verb agreement violation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sentences with word category violation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sentences with combined violations (word category and subject-verb agreement)
Number of subjects: 0
Study: 11956775

Group type: EXPERIMENTAL
Intervention: Transanastomotic stent with multiple holes
Number of subjects: 31

Group type: COMPARATOR
Intervention: No upper system drainage (Control)
Number of subjects: 31
Study: 11325444

Group type: EXPERIMENTAL
Intervention: Xialine (a xanthan gum‐based saliva substitute)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 9068813

Group type: EXPERIMENTAL
Intervention: Injection of killed Mycobacterium vaccae as immunotherapy after 1 month of treatment
Number of subjects: 102

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Immunotherapy (M. vaccae)
Number of subjects: 102
Study: 8439253

Group type: EXPERIMENTAL
Intervention: New technique for measuring stretchability of RFM with pelvic tilt analysis
Number of subjects: 71

Group type: COMPARATOR
Intervention: Commonly used clinical method for measuring stretchability of RFM
Number of subjects: 71

Group type: COMPARATOR
Intervention: X-ray measurements for pelvic tilt analysis
Number of subjects: 71

Group type: COMPARATOR
Intervention: Electronic goniometer for measuring pelvic tilt
Number of subjects: 71
Study: 2894973

Group type: EXPERIMENTAL
Intervention: Felodipine 2.5mg bid
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Felodipine 5mg bid
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Felodipine 10mg bid
Number of subjects: 109

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study: 31493382

Group type: EXPERIMENTAL
Intervention: Motor skill-based training (6 sessions, 60 minutes total, including two 5-minute blocks of wheelchair propulsion training)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Active control group (dose-matched uninstructed practice)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Inactive control group (no training or practice)
Number of subjects: 34
Study: 28901216

Group type: EXPERIMENTAL
Intervention: Creatine (3g daily)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Vitamin D (25000 IU every two weeks)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 27300158

Group type: EXPERIMENTAL
Intervention: Transperineal ultrasound assessment
Number of subjects: 90

Group type: COMPARATOR
Intervention: Digital vaginal examination
Number of subjects: 90
Study: 24480515

Group type: EXPERIMENTAL
Intervention: Ketamine 0.71mg/kg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ketamine 0.41mg/kg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ketamine (both doses)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Lorazepam (2mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Baseline and 24h postinfusion assessments
Number of subjects: 8
Study: 23564399

Group type: EXPERIMENTAL
Intervention: Electronic diary data monitoring
Number of subjects: 169
Study: 20090366

Group type: EXPERIMENTAL
Intervention: Desmopressin infusion
Number of subjects: 48

Group type: COMPARATOR
Intervention: Saline infusion (Control)
Number of subjects: 48
Study: 18247194

Group type: EXPERIMENTAL
Intervention: Fish oil
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 15758009

Group type: EXPERIMENTAL
Intervention: Radiotherapy plus temozolomide
Number of subjects: 573

Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 573
Study: 14522730

Group type: EXPERIMENTAL
Intervention: Caffeinated coffee (400 mL, 2.5 mmol chlorogenic acid/L)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Decaffeinated coffee (400 mL, 2.5 mmol chlorogenic acid/L)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (400 mL water)
Number of subjects: 9
Study: 10556612

Group type: EXPERIMENTAL
Intervention: Listening Span Test (LST) conditions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study: 8908227

Group type: EXPERIMENTAL
Intervention: Nitroglycerin
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate
Number of subjects: 8
Study: 1852471

Group type: EXPERIMENTAL
Intervention: Heparin 300 u/kg body weight intramuscularly once daily for 3 consecutive days
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.5 mg/kg body weight intravenously, three times daily for three consecutive days
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo (no dexamethasone nor heparin)
Number of subjects: 62
Study: 31247558

Group type: EXPERIMENTAL
Intervention: Brain-computer interface (BCI)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: transcranial direct current stimulation coupled BCI (tDCS-BCI)
Number of subjects: 19
Study: 30376857

Group type: EXPERIMENTAL
Intervention: OncoActive intervention (computer-tailored PA advice, pedometer)
Number of subjects: 478
Study: 26830678

Group type: EXPERIMENTAL
Intervention: CD4-VL (clinical monitoring, quarterly CD4 cell counts, and quarterly VL testing)
Number of subjects: 1211

Group type: COMPARATOR
Intervention: CD4-only (clinical monitoring plus quarterly CD4 cell counts)
Number of subjects: 1211
Study: 24882606

Group type: COMPARATOR
Intervention: Ultrasound-guided posterior TAP block using 15 mL of 0.375% ropivacaine on each side
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Subcostal TAP block with 15 mL of 0.375% ropivacaine on each side
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard general anesthesia
Number of subjects: 60
Study: 22211091

Group type: EXPERIMENTAL
Intervention: Normal Saline (NS)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Lactated Ringer's
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Plasmalyte
Number of subjects: 90
Study: 20663207

Group type: EXPERIMENTAL
Intervention: APC (24 μg/kg/hour for 96 hours)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (similar infusion rate for 96 hours)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: APC
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 17255885

Group type: EXPERIMENTAL
Intervention: Contralateral application of white noise
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 18
Study: 15854388

Group type: EXPERIMENTAL
Intervention: 200 microg budesonide turbuhaler by inhalation every night (Group A)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Oral prednisone 5 mg/d and theophyllin control release tablet 0.2 g twice daily, as well as ventolin aerosol inhalation 200 microg three times daily during asthmatic attack (Group B)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Theophyllin control release tablet 0.2 g twice daily and ventolin aerosol inhalation (200 microg/d) during asthmatic attack (Group C)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Oral prednisone and theophyllin (Group B)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Theophyllin and ventolin (Group C)
Number of subjects: 52
Study: 12204929

Group type: EXPERIMENTAL
Intervention: Intensive case management for a minimum of 12 months
Number of subjects: 595

Group type: COMPARATOR
Intervention: Overall reduced case-load size
Number of subjects: 595
Study: 9659133

Group type: EXPERIMENTAL
Intervention: Barium enema examinations performed by radiographers
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Barium enema examinations performed by radiologists
Number of subjects: 1000
Study: 7650123

Group type: EXPERIMENTAL
Intervention: Starting dose of two ampoules (150 IU) of human menopausal gonadotrophin (HMG) for 7 days (Group 1)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Starting dose of three ampoules (225 IU) of human menopausal gonadotrophin (HMG) for 7 days (Group 2)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Starting dose of three ampoules (225 IU) of human menopausal gonadotrophin (HMG) for 7 days (Group 3)
Number of subjects: 151
Study: 2695883

Group type: EXPERIMENTAL
Intervention: Propolis
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 79708

Group type: EXPERIMENTAL
Intervention: Regimens with rifampicin throughout 4 months
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Regimens with rifampicin for only the first 2 months
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Addition of pyrazinamide in the second 2 months
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Removal of streptomycin from the first 2 months
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: All five regimens
Number of subjects: 5
Study: 30563789

Group type: EXPERIMENTAL
Intervention: sublingual (SL) delivery of double mutant heat-labile toxin LTR192G/L211A (dmLT) at doses of 1-50 µg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: sublingual (SL) delivery of dmLT at doses of 25 or 50 µg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: sublingual (SL) delivery of dmLT (3 doses at days 1, 15, and 29)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: oral administration of dmLT
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: sublingual (SL) and oral routes of dmLT
Number of subjects: 80
Study: 28522637

Group type: EXPERIMENTAL
Intervention: General Anesthesia
Number of subjects: 90

Group type: COMPARATOR
Intervention: Conscious Sedation
Number of subjects: 90
Study: 25857665

Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT), 50 mL via enema from healthy anonymous donors, once weekly for 6 weeks.
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo (50 mL water enema), once weekly for 6 weeks.
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT)
Number of subjects: 75
Study: 23686372

Group type: EXPERIMENTAL
Intervention: Aliskiren 150 mg (escalated to 300 mg at 2 weeks)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Aliskiren in ACEI/ARB subgroup
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo in ACEI/ARB subgroup
Number of subjects: 71
Study: 21712735

Group type: EXPERIMENTAL
Intervention: Body fat‐muscular condition
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Central adiposity‐muscular condition
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Age and time elapsed since menopause
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Basal metabolic rate
Number of subjects: 208
Study: 19297248

Group type: EXPERIMENTAL
Intervention: Paracetamol (6 g daily)
Number of subjects: 1400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1400
Study: 17708609

Group type: EXPERIMENTAL
Intervention: High serum IL-18 levels (>= 10(5) pg/mL)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Low serum IL-18 levels (< 10(5) pg/mL)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Serum IL-18 levels
Number of subjects: 70
Study: 15100587

Group type: EXPERIMENTAL
Intervention: New oral analgesics (ketorolac, diclofenac potassium, bromfenac, tramadol, hydrocodone/ibuprofen fixed combination, celecoxib, rofecoxib, tramadol/acetaminophen, valdecoxib)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: New oral analgesics (5 of the 9 drugs)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: New oral analgesics
Number of subjects: 9
Study: 11535953

Group type: EXPERIMENTAL
Intervention: Misoprostol administered into the posterior vaginal fornix (group M)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Natural prostaglandin E(2) (group P)
Number of subjects: 56
Study: 8986703

Group type: EXPERIMENTAL
Intervention: Synthetic serum substitute
Number of subjects: 45

Group type: COMPARATOR
Intervention: Fetal cord serum (FCS)
Number of subjects: 45
Study: 8098277

Group type: EXPERIMENTAL
Intervention: Atenolol (50 mg)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Propranolol (40 mg)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Lorazepam (2 mg)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 3556381

Group type: EXPERIMENTAL
Intervention: Intravenous administration of meptazinol
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Intramuscular administration of meptazinol
Number of subjects: 7

Group type: COMPARATOR
Intervention: Elderly patients
Number of subjects: 7

Group type: COMPARATOR
Intervention: Young volunteers (ages 20-40 years)
Number of subjects: 7
Study: 31309333

Group type: EXPERIMENTAL
Intervention: Lactobacillus Rhamnosis GG (6 billion colony-forming unit per capsule) twice daily for 100 days
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo capsules for 100 days
Number of subjects: 89
Study: 28652529

Group type: EXPERIMENTAL
Intervention: Evacetrapib 130 mg once daily for 12 weeks
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 26039494

Group type: EXPERIMENTAL
Intervention: Animal-assisted therapy (20 min session with an animal-assisted therapy dog after surgery)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Animal-assisted therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard postoperative care
Number of subjects: 40
Study: 23550779

Group type: EXPERIMENTAL
Intervention: Intracameral injection of Biolon (sodium‐hyaluronate 1%)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No use of OVD (control group)
Number of subjects: 60
Study: 21747241

Group type: EXPERIMENTAL
Intervention: Valsartan/Hydrochlorothiazide 160/12.5 mg combination therapy
Number of subjects: 108

Group type: COMPARATOR
Intervention: Hydrochlorothiazide 12.5 mg monotherapy
Number of subjects: 108

Group type: COMPARATOR
Intervention: Valsartan 160 mg monotherapy
Number of subjects: 108
Study: 18794161

Group type: EXPERIMENTAL
Intervention: Vaginal administration of 400 microg misoprostol every 3 h up to five doses
Number of subjects: 681

Group type: COMPARATOR
Intervention: Sublingual administration of 400 microg misoprostol every 3 h up to five doses
Number of subjects: 681

Group type: EXPERIMENTAL
Intervention: Vaginal administration of 400 microg misoprostol
Number of subjects: 681

Group type: COMPARATOR
Intervention: Sublingual administration of 400 microg misoprostol
Number of subjects: 681

Group type: EXPERIMENTAL
Intervention: Vaginal administration
Number of subjects: 681

Group type: COMPARATOR
Intervention: Sublingual administration
Number of subjects: 681

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 681
Study: 17101852

Group type: EXPERIMENTAL
Intervention: Enalapril (20 mg/d)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Control (no enalapril)
Number of subjects: 114
Study: 15626947

Group type: EXPERIMENTAL
Intervention: Coadministration of DTPa-HBV-IPV/Hib and meningococcal C conjugate vaccines during the same visit
Number of subjects: 452

Group type: COMPARATOR
Intervention: Separate administration of DTPa-HBV-IPV/Hib vaccine and meningococcal C conjugate vaccine
Number of subjects: 452
Study: 11452243

Group type: EXPERIMENTAL
Intervention: Sertraline 100 mg single oral dose in poor metabolizers
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sertraline 100 mg single oral dose in extensive metabolizers
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Desmethylsertraline in poor metabolizers
Number of subjects: 12

Group type: COMPARATOR
Intervention: Desmethylsertraline in extensive metabolizers
Number of subjects: 12
Study: 9506548

Group type: EXPERIMENTAL
Intervention: Deprenyl (selegiline)
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Tocopherol
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Combined treatments
Number of subjects: 800

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 800
Study: 7924781

Group type: EXPERIMENTAL
Intervention: Erythrocyte sodium-lithium (Na-Li) countertransport in IDDM group
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Erythrocyte sodium-lithium (Na-Li) countertransport in IDDM subjects with MA
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Erythrocyte sodium-lithium (Na-Li) countertransport in IDDM subjects without MA
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Correlation between HbA1c and Na-Li countertransport in IDDM group
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Diastolic BP in IDDM group with MA
Number of subjects: 84

Group type: COMPARATOR
Intervention: Erythrocyte sodium-lithium (Na-Li) countertransport in siblings
Number of subjects: 84
Study: 2899413

Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 2
Study: 31961489

Group type: EXPERIMENTAL
Intervention: Stepped-care intervention (2-step intervention: 18-week diet and exercise program followed by 4 treatment subgroups)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Stepped-care intervention
Number of subjects: 171
Study: 30032274

Group type: EXPERIMENTAL
Intervention: ADT group
Number of subjects: 73

Group type: COMPARATOR
Intervention: non-ADT group
Number of subjects: 73
Study: 27216492

Group type: EXPERIMENTAL
Intervention: Metformin DR 500 mg twice-daily
Number of subjects: 26

Group type: COMPARATOR
Intervention: Metformin IR 1000 mg twice-daily
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Metformin DR 1000 mg once-daily in the morning
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Metformin DR 1000 mg once-daily in the evening
Number of subjects: 26
Study: 25610796

Group type: EXPERIMENTAL
Intervention: Autologous cord blood transfusions in conjunction with physical and occupational therapies
Number of subjects: 17

Group type: COMPARATOR
Intervention: Autologous cord blood transfusions
Number of subjects: 17
Study: 23681955

Group type: EXPERIMENTAL
Intervention: Vitamin C (500 mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Allopurinol (up to 100 mg/day)
Number of subjects: 40
Study: 20606024

Group type: EXPERIMENTAL
Intervention: PRP with IVTA (30 eyes)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: PRP with IVB (31 eyes)
Number of subjects: 76

Group type: COMPARATOR
Intervention: PRP only (30 eyes)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: IVTA group (30 eyes)
Number of subjects: 76
Study: 17944983

Group type: EXPERIMENTAL
Intervention: Inhaled adenosine A2A receptor agonist (GW328267X), 25 microg
Number of subjects: 15

Group type: COMPARATOR
Intervention: Fluticasone propionate, 250 microg
Number of subjects: 15